High Court Boosts Biosimilars By Allowing Early Notice
The U.S. Supreme Court on Monday ruled that biosimilar makers can give 180-day notice of sales before their products win approval, a major decision that will speed up access to the...To view the full article, register now.
Already a subscriber? Click here to view full article